肠易激综合征女性卵巢癌风险的观察性队列研究
该观察性队列研究利用行政索赔数据比较有或无肠易激综合征(IBS)诊断女性间的卵巢癌发病率。结果显示,IBS诊断后3个月(HR=1.71,95%CI:1.08-2.70,p=0.02)和6个月(HR=1.43,95%CI:1.06-1.93,p=0.02)卵巢癌风险升高,但8个月后时间点无差异。部分卵巢癌症状女性可能被误诊为IBS,但IBS与卵巢癌无因果关联。
要点
- IBS诊断后3个月卵巢癌风险HR=1.71,6个月HR=1.43。
- 8个月后卵巢癌风险未见升高。
- 部分卵巢癌症状可能被误诊为IBS。
核心结论
- IBS诊断后短期内卵巢癌风险升高,但8个月后无差异,IBS与卵巢癌无因果关联。
研究设计与样本
- 基于行政索赔数据的观察性队列研究,比较有或无IBS诊断女性的卵巢癌发病率。
主要发现
- IBS诊断后3个月卵巢癌风险HR=1.71(95%CI:1.08-2.70,p=0.02)。
- IBS诊断后6个月卵巢癌风险HR=1.43(95%CI:1.06-1.93,p=0.02)。
- IBS诊断后8个月以上时间点卵巢癌风险未见升高。
临床怎么用
- 对IBS诊断后短期内出现症状的女性,需警惕卵巢癌可能,避免误诊。
局限性
- 需进一步研究验证结果并明确卵巢癌筛查时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We compared ovarian cancer incidence between women with and without an index irritable bowel syndrome (IBS) diagnosis using administrative claims data. Risk of ovarian cancer was higher at 3 (hazard ratio [HR] = 1.71, 95% CI: 1.08-2.70, p = 0.02) and 6 (HR = 1.43, 95% CI: 1.06-1.93, p = 0.02) months after an index IBS diagnosis, but not at time points after 8 months, in women with IBS compared to those without. Some women with symptoms of ovarian cancer may be misdiagnosed with IBS, although IBS is not causally linked to ovarian cancer. Further studies are needed to validate findings and clarify when ovarian cancer screening may be warranted.
引用
- Shin A, Xu H, Sarnoff R, et al. Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome. Aliment Pharmacol Ther. 2025. PMID: 41081454. doi:10.1111/apt.70277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。